Literature DB >> 18611991

Absence of diffuse cervical cord tissue damage in early, non-disabling relapsing-remitting MS: a preliminary study.

M Rovaris1, E Judica, A Ceccarelli, A Ghezzi, V Martinelli, G Comi, M Filippi.   

Abstract

BACKGROUND: Magnetization transfer (MT) magnetic resonance imaging (MRI) can provide quantitative information about the severity of tissue damage in the cervical cord of patients with multiple sclerosis (MS). MT MRI-derived measures of cord damage are correlated with the severity of disease-related locomotor disability.
OBJECTIVES: The objective of this study was to investigate whether MT MRI-detectable cervical cord damage is present in early relapsing-remitting (RR) MS. SUBJECTS AND METHODS: We studied 23 patients with 'early' RR MS (i.e., with a disease duration shorter than 5 years) and 10 age-matched healthy control subjects. During a single session, the following sequences were acquired using a 1.5 T scanner: (a) brain dual-echo turbo spin echo; (b) cervical cord fast short-tau inversion recovery; (c) cervical cord gradient echo, without and with MT pulse. Brain T2 lesion volume was measured. Cervical cord lesions were counted and normalized histograms of cord MT ratio (MTR) were produced.
RESULTS: One or more cervical cord lesions were found in nine patients (39%). The average cord MTR and the mean histogram peak height values did not differ between patients and controls. There was no significant correlation between brain T2 lesion volume and cervical cord MTR histogram-derived metrics.
CONCLUSIONS: Cervical cord tissue damage seems to be limited to macroscopic lesions in patients with early, non-disabling RR MS. Longitudinal studies are warranted to define the dynamics of MS-related cord damage accumulation over time later on in the course of the disease.

Entities:  

Mesh:

Year:  2008        PMID: 18611991     DOI: 10.1177/1352458507088103

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  6 in total

1.  Rapid, high-resolution quantitative magnetization transfer MRI of the human spinal cord.

Authors:  Alex K Smith; Richard D Dortch; Lindsey M Dethrage; Seth A Smith
Journal:  Neuroimage       Date:  2014-03-13       Impact factor: 6.556

2.  The relationships among MRI-defined spinal cord involvement, brain involvement, and disability in multiple sclerosis.

Authors:  Adam B Cohen; Mohit Neema; Ashish Arora; Elisa Dell'oglio; Ralph H B Benedict; Shahamat Tauhid; Daniel Goldberg-Zimring; Christian Chavarro-Nieto; Antonella Ceccarelli; Joshua P Klein; James M Stankiewicz; Maria K Houtchens; Guy J Buckle; David C Alsop; Charles R G Guttmann; Rohit Bakshi
Journal:  J Neuroimaging       Date:  2011-03-29       Impact factor: 2.486

3.  Site-specific chemokine expression regulates central nervous system inflammation and determines clinical phenotype in autoimmune encephalomyelitis.

Authors:  Joshua S Stoolman; Patrick C Duncker; Amanda K Huber; Benjamin M Segal
Journal:  J Immunol       Date:  2014-06-13       Impact factor: 5.422

Review 4.  Translating state-of-the-art spinal cord MRI techniques to clinical use: A systematic review of clinical studies utilizing DTI, MT, MWF, MRS, and fMRI.

Authors:  Allan R Martin; Izabela Aleksanderek; Julien Cohen-Adad; Zenovia Tarmohamed; Lindsay Tetreault; Nathaniel Smith; David W Cadotte; Adrian Crawley; Howard Ginsberg; David J Mikulis; Michael G Fehlings
Journal:  Neuroimage Clin       Date:  2015-12-04       Impact factor: 4.881

5.  Test-retest reliability of myelin imaging in the human spinal cord: Measurement errors versus region- and aging-induced variations.

Authors:  Simon Lévy; Marie-Claude Guertin; Ali Khatibi; Aviv Mezer; Kristina Martinu; Jen-I Chen; Nikola Stikov; Pierre Rainville; Julien Cohen-Adad
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

6.  Additive Effect of Spinal Cord Volume, Diffuse and Focal Cord Pathology on Disability in Multiple Sclerosis.

Authors:  Michaela Andelova; Tomas Uher; Jan Krasensky; Lukas Sobisek; Eliska Kusova; Barbora Srpova; Karolina Vodehnalova; Lucie Friedova; Jiri Motyl; Jana Lizrova Preiningerova; Eva Kubala Havrdova; Dana Horakova; Manuela Vaneckova
Journal:  Front Neurol       Date:  2019-08-06       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.